Prof. Dr. MURAT TÖRÜNER

Metrikler

Yayın

193

Yayın (WoS)

160

Yayın (Scopus)

133

Atıf (WoS)

3980

H-İndeks (WoS)

Atıf (Scopus)

4203

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

121

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Eğitim Bilgileri

1999 - 2002

Tıpta Yandal Uzmanlık

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye

1994 - 1999

Tıpta Uzmanlık

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye

1987 - 1993

Lisans

Hacettepe Üniversitesi, Tıp Fakültesi, Tıp Pr., Türkiye

Yaptığı Tezler

2002

Tıpta Yandal Uzmanlık

Endoskopi ünitesine başvuran hastalarda barrett özofagusu sıklığı ve üst gastrointestinal semptomlarla olan ilişkisi

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1999

Tıpta Uzmanlık

Hepatik ensefalopatili bir hayvan modelinde opioderjik sistem aktivitesi ölçüsü olarak adenilat siklaz enzim aktivitesinin incelenmesi

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

Yabancı Diller

C1 İleri

İngilizce

Araştırma Alanları

Tıp

Dahili Tıp Bilimleri

İç Hastalıkları

Gastroenteroloji-(Hepatoloji)

Sağlık Bilimleri

Akademik Ünvanlar / Görevler

2010 - Devam Ediyor

Prof. Dr.

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

2005 - 2010

Doç. Dr.

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

2003 - 2005

Araştırma Görevlisi

Mayo Clinic, School Of Medicine, Department Of Gastroenteroloji

2002 - 2005

Uzman

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1999 - 2002

Uzman

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1994 - 1999

Araştırma Görevlisi

Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1997 - 1998

Araştırma Görevlisi

Yale University, Üretim Yönetimi, Hepatik Hemodinamik Laboratuvar

Yönetimsel Görevler

2008 - 2012

Dekan Yardımcısı

Ankara Üniversitesi

Verdiği Dersler

Lisans

Barsak Hastalıkları

İnflamatuvar Barsak Hastalıkları

Approach to a patient with GI Bleeding

Inflammatory Bowel Diseases

Barsak Hastalıkları

Fonksiyonel Barsak Hastalıkları

Alt GİS Kanamaları

Yönetilen Tezler

2023

Tıpta Uzmanlık

Biyolojik ajan kullanan inflamatuar barsak hastalarında primer ve sekonder yanıtsızlık oranları ve bu oranlar üzerinde etkili faktörler

Törüner M. (Danışman)

Z.EROĞLU(Öğrenci)

2017

Tıpta Uzmanlık

İnflamatuvar barsak hastalığı'nda sitomegalovirus (CMV) enfeksiyonu sıklığı, risk faktörleri ve klinik seyir

TÖRÜNER M. (Danışman)

B.MANTI(Öğrenci)

2015

Tıpta Uzmanlık

İnflamatuar barsak hastalığı olan bireylerde hastalık tipi, aktivitesinin cinsel yaşantı ve hayat kalitesi üzerine etkisi

TÖRÜNER M. (Danışman)

E.BULUT(Öğrenci)

2011

Tıpta Uzmanlık

Kolorektal kanserlerde vitamin D reseptör ekspresyonunun kolorektal kanserlerde evre ile ilişkisi ve prognoz üzerine etkisi

TÖRÜNER M. (Danışman)

M.SEZGİN(Öğrenci)

2011

Tıpta Uzmanlık

İltihabi barsak hastalıklarında interlökin 23 reseptör ve atg16l1 gen polimorfizmleri ve klinikle ilişkisi

TÖRÜNER M. (Danışman)

G.KABAÇAM(Öğrenci)

Makaleler

2025

1. Efficacy and safety of infliximab in patients with autoimmune hepatitis

Efe C., Lytvyak E., EŞKAZAN T., Liberal R., Androutsakos T., Gökçe D., et al.

Hepatology , cilt.81, sa.6, ss.1660-1670, 2025 (SCI-Expanded, Scopus)

2025

2. Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study

Dignass A., Magro F., D’Amico F., Bamias G., Caprioli F. A., Franchimont D., et al.

United European Gastroenterology Journal , 2025 (SCI-Expanded, Scopus)

2024

3. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gökçe D. T., Gumussoy M., Kiremitçi S., Bodakçi E., Yılmaz V., et al.

JOURNAL OF HEPATOLOGY , cilt.80, ss.479, 2024 (SCI-Expanded, Scopus)

2024

4. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gokce D. T., Gumussoy M., KİREMİTCİ S., Bodakci E., Yilmaz V., et al.

JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded)

2024

5. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

Turan D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.

GASTROENTEROLOGY , cilt.166, sa.5, ss.1642, 2024 (SCI-Expanded, Scopus)

2023

6. The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver

Sezgin O., AKPINAR H., Özer B., TÖRÜNER M., Bal K., Bor S.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.6, ss.652-664, 2023 (SCI-Expanded)

2023

7. Epigenetics of Inflammatory Bowel Diseases

TÖRÜNER M., Ünal N. G.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.5, ss.437-448, 2023 (SCI-Expanded)

2023

8. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta

Kalkan Ç., Yılmaz Y., Erdoğan B. D., SAVAŞ B., Yurdcu E., Çalışkan A., et al.

Journal of Viral Hepatitis , cilt.30, sa.5, ss.406-416, 2023 (SCI-Expanded, Scopus)

2023

9. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.

Torres J., Chaparro M., Julsgaard M., Katsanos K., Zelinkova Z., Agrawal M., et al.

Journal of Crohn's & colitis , cilt.17, ss.1-27, 2023 (SCI-Expanded, Scopus)

2023

10. Management of iron-deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review.

Lanas A., Andrews J. M., Lau J., Toruner M., Bromley S. E., Gralnek I. M.

Journal of gastroenterology and hepatology , cilt.38, sa.1, ss.23-33, 2023 (SCI-Expanded, Scopus)

2022

11. The Impact of Inflammatory Bowel Diseases and Related Medications on COVID-19 Severity and Outcome: A Tertiary Referral Center Experience from Turkey.

Er R. E., Duman S., Bodakçı E., Yarcı B., Soykan A. İ., Törüner M.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.12, ss.1025-1032, 2022 (SCI-Expanded)

2022

12. Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study.

Celasin H., Törüner M., Aghayeva S., Bayramov N., Vardanyan A., Nanaeva B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, ss.1004-1011, 2022 (SCI-Expanded)

2022

13. Culture media composition influences patient-derived organoids ability to predict therapeutic response in gastrointestinal cancers.

Hogenson T. L., Xie H., Phillips W. J., Toruner M. D., Li J. J., Horn I. P., et al.

JCI insight , cilt.7, 2022 (SCI-Expanded, Scopus)

2022

14. Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases

Enver A., Özmeriç Kurtuluş N., İşler S. Ç., Törüner M., Fidan Ç., Demirci G., et al.

JOURNAL OF PERIODONTOLOGY , cilt.93, sa.11, ss.1649-1660, 2022 (SCI-Expanded, Scopus)

2022

15. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Savarino E., Zingone F., Barberio B., Marasco G., AKYÜZ F., AKPINAR H., et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , cilt.10, sa.6, ss.556-584, 2022 (SCI-Expanded, Scopus)

2022

16. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.5, ss.406-413, 2022 (SCI-Expanded, Scopus, TRDizin)

2021

17. Assessment of Imaging Features of Crohn's Disease with MR Enterography

Onay M., Erden A., Binboga A. B., Altay C. M., Törüner M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.8, ss.631-639, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

18. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Kucharzik T., Ellul P., Greuter T., Rahier J. F., Verstockt B., Abreu C., et al.

Journal of Crohn's & colitis , cilt.15, sa.6, ss.879-913, 2021 (SCI-Expanded, Scopus)

2021

19. Natural History of Cirrhosis: Changing Trends in Etiology Over the Years

İDİLMAN R., Aydogan M., Oruncu M. B., Kartal A., ELHAN A. H., Ellik Z., et al.

DIGESTIVE DISEASES , cilt.39, sa.4, ss.358-365, 2021 (SCI-Expanded, Scopus)

2021

20. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic

TÖRÜNER M., Kalkan I. H., Akyuz F., Tezel A., ÇELİK A. F.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.6, ss.488-492, 2021 (SCI-Expanded, Scopus)

2020

21. New Aspects of the Epigenetics of Pancreatic Carcinogenesis.

Toruner M., Fernandez-Zapico M. E., Pin C. L.

Epigenomes , cilt.4, sa.3, 2020 (ESCI)

2020

22. Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study

Yamamoto-Furusho J. K., Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., et al.

DIGESTIVE AND LIVER DISEASE , cilt.52, sa.8, ss.869-877, 2020 (SCI-Expanded, Scopus)

2019

23. Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey

SEZGİN O., AKARSU M., Ozer B., TÖRÜNER M., BAL K., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.12, ss.1009-1022, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

24. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management

TÖRÜNER M., AKARSU M., Akyuz F., Dagli U., Hamzaoglu H. O., Tezel A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

25. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Sands B. E., Peyrin-Biroulet L., Loftus E. V., Danese S., Colombel J., TÖRÜNER M., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.381, sa.13, ss.1215-1226, 2019 (SCI-Expanded, Scopus)

2019

26. Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the 'EXPLORE' study

Ye B. D., Furusho J. K. Y., Khan M. R. Q., Fadeeva O., Demuth D., Qian J., et al.

JOURNAL OF CROHNS & COLITIS , cilt.13, 2019 (SCI-Expanded, Scopus)

2019

27. The influence of disease type and activity to sexual life and health quality in inflammatory bowel disease

Bulut E. A., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.1, ss.33-39, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

28. Backwash ileitis in ulcerative colitis: Are there MR enterographic features that distinguish it from Crohn disease?

Erden A., KURU ÖZ D., GÜRSOY ÇORUH A., Erden I., Ates F. S. O., TÖRÜNER M.

EUROPEAN JOURNAL OF RADIOLOGY , cilt.110, ss.212-218, 2019 (SCI-Expanded, Scopus)

2018

29. COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN'S DISEASE FOR TURKEY

Arhan M., Tezel H. A., TÖRÜNER M., Bilaloglu B., Koral S., Ozer E.

VALUE IN HEALTH , cilt.21, 2018 (SCI-Expanded)

2018

30. A rare cause of small bowel obstruction

PEKER E., Erden A., Erden I., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.2, ss.237-238, 2018 (SCI-Expanded)

2017

31. MR Enterography in Crohn's disease complicated with enteroenteric fistula

Erden A., ÜNAL S., Akkaya H. E., Onay M., TÖRÜNER M., Gencturk Z. B., et al.

EUROPEAN JOURNAL OF RADIOLOGY , cilt.94, ss.101-106, 2017 (SCI-Expanded, Scopus)

2017

32. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report

AKARSU M., Cetiner M., Keshav S., Ormeci N., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, sa.2, ss.81-87, 2017 (SCI-Expanded, Scopus, TRDizin)

2017

33. Anti-TNF treatments in Crohn's disease and improvement in work productivity and quality of life: an observational study from Turkey

TÖRÜNER M., Basaranoglu M., Atug O., Sentruk O., Akyuz F., Unsal B., et al.

JOURNAL OF CROHNS & COLITIS , cilt.11, 2017 (SCI-Expanded)

2016

34. Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease

Ustun Y., Kilincalp S., Coban S., Coskun Y., YÜKSEL İ., ONGUN A., et al.

MEDICAL SCIENCE MONITOR , cilt.22, ss.3943-3950, 2016 (SCI-Expanded, Scopus)

2016

35. Anti-INF-α agents and serum lipids in inflammatory bowel diseases

Kalkan C., Karakaya F., TÖRÜNER M., Cetinkaya H., Soykan I.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , sa.4, 2016 (SCI-Expanded, Scopus)

2016

36. Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey

KÜÇÜKŞAHİN O., ATEŞ A., Turkcapar N., TÖRÜNER M., Turgay M., Duman T., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , sa.4, ss.317-324, 2016 (SCI-Expanded, Scopus, TRDizin)

2015

37. Association of Matrix Metalloproteinases and Their Tissue Inhibitor With Disease Activity and Development in Spondyloarthropathy and Inflammatory Bowel Disease

Elmas D., ŞAHİN A., KÜÇÜKŞAHİN O., Turkcapar N., TÖRÜNER M., Cetinkaya H., et al.

ARCHIVES OF RHEUMATOLOGY , cilt.30, sa.3, ss.191-197, 2015 (SCI-Expanded)

2015

38. Health Quality and Sexual Dysfunction in Turkish IBD Patients

TÖRÜNER M., Ates E., Kalkan C., Karakaya F., Cetinkaya H., Soykan I.

JOURNAL OF CROHNS & COLITIS , cilt.9, 2015 (SCI-Expanded)

2014

39. Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients?

Ozen M., Keskin O., TOPÇUOĞLU P., Ozturk B., Ozgul S., Ilgen U., et al.

LEUKEMIA & LYMPHOMA , cilt.55, sa.7, ss.1697-1698, 2014 (SCI-Expanded, Scopus)

2014

40. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines

Gomollon F., Chowers Y., Danese S., Dignass A., Nielsen O. H., Lakatos P. L., et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.39, sa.7, ss.743-744, 2014 (SCI-Expanded, Scopus)

2014

41. ERAP-1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and anyklosing spondylitis

KÜÇÜKŞAHİN O., Turkcapar N., Ates A., TÖRÜNER M., Duman T., Cetinkaya H., et al.

JOURNAL OF CROHNS & COLITIS , cilt.8, 2014 (SCI-Expanded)

2014

42. Prevalence of iron deficiency anemia and iron deficiency in a single center Turkish IBD cohort

TÖRÜNER M., Kalkan C., Keskin O., Cetinkaya H., Soykan I.

JOURNAL OF CROHNS & COLITIS , cilt.8, 2014 (SCI-Expanded, Scopus)

2014

43. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)

Sebastian S., Hernandez V., Myrelid P., Kariv R., Tsianos E., TÖRÜNER M., et al.

JOURNAL OF CROHNS & COLITIS , cilt.8, sa.1, ss.5-18, 2014 (SCI-Expanded, Scopus)

2014

44. The Frequency of Spondyloarthropathy in Inflammatory Bowel Diseases

KÜÇÜKŞAHİN O., ATEŞ A., TÖRÜNER M., Turkcapar N., ŞAHİN A., Turgay M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded)

2014

45. The Role of Anti-Cd74 Antibody in The Development of Spondyloarthropathy in Ankylosing Spondylitis and Inflammatory Bowel Disease and Disease Activity

Yurumez S., KÜÇÜKŞAHİN O., Turgay M., ATEŞ A., TÖRÜNER M., Cetinkaya H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded)

2014

46. Ülseratif kolitli hastalarda displazi varlığı ve displastik mukozada p53 ve Ki 67 ekspresyonu

BEKTAŞ M., SAVAŞ B., ÇETİNKAYA H., TÖRÜNER M., ENSARİ A., DOĞANAY B., et al.

Akademik Gastroenteroloji Dergisi , cilt.13, sa.2, ss.41-46, 2014 (Hakemli Dergi)

2013

47. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method

Reinisch W., Chowers Y., Danese S., Dignass A., Gomollon F., Nielsen O. H., et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.38, sa.9, ss.1109-1118, 2013 (SCI-Expanded, Scopus)

2013

48. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

Feagan B. G., Sandborn W. J., D'Haens G., Pola S., McDonald J. W., Rutgeerts P., et al.

Gastroenterology , cilt.145, sa.1, 2013 (SCI-Expanded)

2013

49. Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging

TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., Bay M., Ayyildiz E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.2, ss.219-220, 2013 (SCI-Expanded, Scopus, TRDizin)

2012

50. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells

Bektaş M., Saraç N., Çetinkaya H., TÖRÜNER M., ERDEMLİ E., Keskin O., et al.

Annals of Gastroenterology , cilt.25, sa.2, ss.123-127, 2012 (Scopus)

2012

51. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells.

Bektaş M., Saraç N., Cetinkaya H., Törüner M., Erdemli E., Keskin O., et al.

Annals of gastroenterology , cilt.25, sa.2, ss.123-127, 2012 (Scopus)

2012

52. Can azathioprine/6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: What is the most appropriate time for this?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, ss.17-20, 2012 (SCI-Expanded, Scopus, TRDizin)

2012

53. How long should we treat patients with azathioprine/6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, ss.13-16, 2012 (SCI-Expanded)

2011

54. The Effect of Endogenous Hypergastrinemia on Lower Esophageal Sphincter Pressure and Esophageal Motility

Yakut M., Kabacam G., Bektas M., Cetinkaya H., TÖRÜNER M., Soykan I.

HEPATO-GASTROENTEROLOGY , cilt.58, sa.112, ss.1989-1992, 2011 (SCI-Expanded)

2011

55. The effect of age and Helicobacter pylori infection on gastric epithelial cell kinetics

Coban S., Soykan I., TÖRÜNER M., AKBULUT H., Atli T., ENSARİ A.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.35, sa.10, ss.661-665, 2011 (SCI-Expanded, Scopus)

2011

56. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D

Seven G., Karatayli S. C., KÖSE S. K., Yakut M., Kabacam G., TÖRÜNER M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.3, ss.305-314, 2011 (SCI-Expanded, Scopus, TRDizin)

2010

57. Is the prevalence of intestinal metaplasia at the squamocolumnar junction different in patients with progressive sytemic sclerosis?

VARDAR R., Vardar E., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.21, sa.3, ss.251-256, 2010 (SCI-Expanded, Scopus, TRDizin)

2010

58. The Characteristics and Clinical Outcome of Drug-induced Liver Injury A Single-center Experience

İDİLMAN R., Bektas M., Cinar K., TÖRÜNER M., Cerit E. T., DOĞANAY ERDOĞAN B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.44, sa.6, 2010 (SCI-Expanded, Scopus)

2010

59. The Impact of the Speed of Food Intake on Intraesophageal Reflux Events in Obese Female Patients

Vardar R., Valytova E., Belen E., Bayrakci B., TÖRÜNER M.

GASTROENTEROLOGY , cilt.138, sa.5, 2010 (SCI-Expanded)

2010

60. Sexual Intercourse Does Not Increase the Reflux on Patients With Gastroesophageal Reflux Disease

TÖRÜNER M., Vardar R., Valytova E., Belen E.

GASTROENTEROLOGY , cilt.138, sa.5, 2010 (SCI-Expanded)

2010

61. The Feasibility of 24 Hour Ambulatory Multichannel Intraluminal Impedance in Patients With Progressive Systemic Sclerosis

Bayrakci B., Yargucu F., Vardar R., Oksel F., TÖRÜNER M.

GASTROENTEROLOGY , cilt.138, sa.5, 2010 (SCI-Expanded)

2010

62. Proteasome Inhibitor Bortezomib Decreases Mouse Colitis-Associated Tumor Formation

TÖRÜNER M., Nalluri M. K., Han J. J., Sanderson S., Inderhaug C., Callagy G., et al.

GASTROENTEROLOGY , cilt.138, sa.5, 2010 (SCI-Expanded)

2010

63. What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.21, sa.1, ss.107-112, 2010 (SCI-Expanded)

2010

64. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease

TÖRÜNER M., KİTAPÇIOĞLU G., Solak Z. A., Ertilav M., ERDİNÇ M.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.25, sa.2, ss.309-313, 2010 (SCI-Expanded, Scopus)

2010

65. Ankara Üniversitesi Tıp Fakültesi Hastaneleri’nde Maliyet Analizi

Esatoğlu A. E., Ağırbaş İ., Doğanay Payziner P., Akbulut Y., Göktaş B., Özatkan Y., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.63, sa.1, ss.17-27, 2010 (Hakemli Dergi)

2010

66. Ankara Üniversitesi Tıp Fakültesi Hastaneleri'nde Maliyet Analizi

ESATOĞLU A. E., AĞIRBAŞ İ., Payzıner P. D., AKBULUT Y., GÖKTAŞ B., Ozatkan Y., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.63, sa.1, ss.17-27, 2010 (Hakemli Dergi)

2010

67. The frequency of sexual-physical abuse history in irritabl bowel syndrome patients and diagnostic relation with major depressive disorder history

EKER M. Ç., KASAP E., ELBİ H., TÖRÜNER M.

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.11, sa.2, ss.120-126, 2010 (SCI-Expanded)

2009

68. Esophageal intramural pseudodiverticulosis associated with achalasia: an unusual endoscopic appearance

TURAN İ., Ozen E., TÖRÜNER M., Ozutemiz O.

ENDOSCOPY , cilt.41, 2009 (SCI-Expanded, Scopus)

2009

69. Validity and Reliability of a Turkish Version of the Fecal Incontinence Quality of Life Scale

Dedeli O., Fadiloglu C., TÖRÜNER M.

JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING , cilt.36, sa.5, ss.532-538, 2009 (SCI-Expanded, SSCI, Scopus)

2009

70. The evaluation of VEGF and endostatin expressions and serum levels in ulcerative colitis

Savas B., Kahramanoglu E., Ustun Y., Cetinkaya H., TÖRÜNER M., Ozden A., et al.

VIRCHOWS ARCHIV , cilt.455, ss.125-126, 2009 (SCI-Expanded)

2009

71. The additive effect of ethanol and extract of cigarette smoke on rabbit esophagus epithelium

TÖRÜNER M., Capanoglu D.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.24, sa.2, ss.316-321, 2009 (SCI-Expanded, Scopus)

2009

72. Eating Disorder Symptoms Improved by Antireflux Surgery: A Case Report with a Six-Year Follow Up

Eraslan D., Ozturk O., TÖRÜNER M.

ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES , cilt.46, sa.3, ss.231-235, 2009 (SCI-Expanded, SSCI, Scopus)

2008

73. Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey

Bayrakci B., Kasap E., Kitapcioglu G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.19, sa.3, ss.145-151, 2008 (SCI-Expanded, Scopus, TRDizin)

2008

74. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease

Sapmaz A., Karatayli S. C. O., Dagli U., Kilic Z. M. Y., TÖRÜNER M., Celik Y., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.19, sa.3, ss.168-173, 2008 (SCI-Expanded, Scopus, TRDizin)

2008

75. Endoscopic findings of gastroesophageal reflux disease in Turkey: Multicenter prospective study (Gorhen)

TÖRÜNER M., Vardar R., Vardar E., Takamz S., Mungan Z. A.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded, Scopus)

2008

76. Risk factors for opportunistic infections in patients with inflammatory bowel disease

TÖRÜNER M., Loftus E. V., Harmsen W. S., Zinsmeister A. R., Orenstein R., Sandborn W. J., et al.

GASTROENTEROLOGY , cilt.134, sa.4, ss.929-936, 2008 (SCI-Expanded, Scopus)

2008

77. PREVALANCE OF FECAL INCONTINENCE AND ITS EFFECT ON QUALITY OF LIFE IN ELDERLY INDIVIDUALS LIVING IN NURSING HOMES IN THE CITY OF IZMIR

Dedeli O., Fadiloglu C., TURAN İ., TÖRÜNER M.

TURK GERIATRI DERGISI-TURKISH JOURNAL OF GERIATRICS , cilt.11, sa.1, ss.33-41, 2008 (SCI-Expanded, Scopus, TRDizin)

2007

78. Prevalence patterns of gastric cancers in Turkey: Model of a developing country with high occurrence of Helicobacter pylori

TÖRÜNER M., Vardar R., Ormeci N., Memik F., Suleymanlar I., Oguz D., et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.22, sa.12, ss.2242-2245, 2007 (SCI-Expanded, Scopus)

2007

79. The acute effect of oral ethanol intake on gastric myoelectrical activity in healthy volunteers

Kobak A. C., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.4, ss.221-224, 2007 (SCI-Expanded, Scopus, TRDizin)

2007

80. Aspirin and gastrointestinal toxicity

TÖRÜNER M.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.7, ss.27-30, 2007 (SCI-Expanded, Scopus, TRDizin)

2007

81. Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease

TÖRÜNER M., Kitapcioglu G., Dettmar P., Baxter T.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.5, sa.9, ss.1035-1039, 2007 (SCI-Expanded, Scopus)

2007

82. The effect of laparoscopic Nissen fundoplication on laryngeal findings and voice quality

Ogut F., Ersin S., Engin E. Z., Kirazli T., Midilli R., Unsal G., et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , cilt.21, sa.4, ss.549-554, 2007 (SCI-Expanded, Scopus)

2007

83. Does an acute increase of intraabdominal pressure effect esophageal sphincter pressure?

Yimaz N., Musoglu A., ÖNER K. S., TÖRÜNER M.

HEPATO-GASTROENTEROLOGY , cilt.54, sa.74, ss.434-437, 2007 (SCI-Expanded, Scopus)

2007

84. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community

Kitapcioglu G., MANDIRACIOĞLU A., BOR C., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.1, ss.14-19, 2007 (SCI-Expanded, Scopus, TRDizin)

2007

85. Methodology and possibilities of manometry in the diagnosis of esophageal disease

Bordin D. S., TÖRÜNER M., Vasilyev Y. V.

TERAPEVTICHESKII ARKHIV , cilt.79, sa.4, ss.63-71, 2007 (SCI-Expanded)

2007

86. Use of case-based exams as an instructional teaching tool to teach clinical reasoning

Durak H. I., ÇALIŞKAN S. A., TÖRÜNER M., Van der Vleuten C.

MEDICAL TEACHER , cilt.29, sa.6, 2007 (SCI-Expanded, Scopus)

2006

87. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease

Celik Y., Dagli U., Kilic M., TÖRÜNER M., Ozen S., Ozkan M. M., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.41, sa.5, ss.559-565, 2006 (SCI-Expanded, Scopus)

2006

88. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Turkcapar N., TÖRÜNER M., Soykan I., Aydintug O., Cetinkaya H., Duzgun N., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.26, sa.7, ss.663-668, 2006 (SCI-Expanded, Scopus)

2006

89. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease

Ozen S. C., Dagli U., Kilic M. Y., TÖRÜNER M., Celik Y., Ozkan M., et al.

JOURNAL OF GASTROENTEROLOGY , cilt.41, sa.4, ss.304-310, 2006 (SCI-Expanded, Scopus)

2006

90. Antianoikis effect of nuclear factor-kappa B through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1

TÖRÜNER M., Fernandez-Zapico M., Sha J., Pham L., Urrutia R., Egan L.

JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.281, sa.13, ss.8686-8696, 2006 (SCI-Expanded, Scopus)

2006

91. NF-kappa B signaling - Pros and cons of altering NF-kappa B as a therapeutic approach

Egan L. J., TÖRÜNER M.

INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS , cilt.1072, ss.114-122, 2006 (SCI-Expanded, Scopus)

2005

92. Preswallowing dystonia

Ertekin C., Aydogdu I., Ozdemirkiran T., Secil Y., TÖRÜNER M.

DYSPHAGIA , cilt.20, sa.1, ss.15-18, 2005 (SCI-Expanded, Scopus)

2005

93. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication

Duman D., TÖRÜNER M., Ozutemiz O., Sahin T., Oguz D., Isitan F., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.17, sa.12, ss.1357-1361, 2005 (SCI-Expanded, Scopus)

2005

94. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season

Onbasi K., Sin A., Doganavsargil B., Onder G., TÖRÜNER M., Sebik F.

CLINICAL AND EXPERIMENTAL ALLERGY , cilt.35, sa.11, ss.1423-1431, 2005 (SCI-Expanded, Scopus)

2005

95. Swallow-induced syncope in a patient with achalasia

TURAN İ., Ersoz G., TÖRÜNER M.

DYSPHAGIA , cilt.20, sa.3, ss.238-240, 2005 (SCI-Expanded, Scopus)

2005

96. Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B

Yurdaydin C., Bozkaya H., Cetinkaya H., Sahin T., Karaoguz D., TÖRÜNER M., et al.

Journal of Viral Hepatitis , cilt.12, sa.3, ss.262-268, 2005 (SCI-Expanded, Scopus)

2005

97. Manometric assessment of esophageal motility in patients with primary Sjorgren's syndrome

Turk T., Pirildar T., Tunc E., TÖRÜNER M., Doganavsargil E.

RHEUMATOLOGY INTERNATIONAL , cilt.25, sa.4, ss.246-249, 2005 (SCI-Expanded, Scopus)

2005

98. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

TÖRÜNER M., Harewood G., Loftus E., Sandborn W., Tremaine W., Faubion W., et al.

INFLAMMATORY BOWEL DISEASES , cilt.11, sa.5, ss.428-434, 2005 (SCI-Expanded, Scopus)

2005

99. Gastroesophageal reflux disease in a low-income region in Turkey

TÖRÜNER M., Mandiracioglu A., Kitapcioglu G., Caymaz-Bor C., Gilbert R.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.100, sa.4, ss.759-765, 2005 (SCI-Expanded, Scopus)

2004

100. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.

TÖRÜNER M., Erkan Ö., Soykan I., Bozdayi M., Çetinkaya H., Yurdaydin C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.15, sa.4, ss.250-2, 2004 (Scopus)

2004

101. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.

TÖRÜNER M., Bektaş M., Çetinkaya H., Soykan I., Özden A.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.15, sa.4, ss.225-8, 2004 (Scopus)

2004

102. Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution

Myhre G., TÖRÜNER M., Abraham S., Egan L.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , cilt.287, sa.6, 2004 (SCI-Expanded, Scopus)

2004

103. Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms

TÖRÜNER M., Soykan I., Ensari A., KUZU I., Yurdaydin C., Ozden A.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.19, sa.5, ss.535-540, 2004 (SCI-Expanded, Scopus)

2004

104. Colorectal cancer surveillance in inflammatory bowel diseases

TÖRÜNER M.

Turkish Journal of Cancer , cilt.34, sa.2, ss.55-59, 2004 (Scopus)

2004

105. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

Idilman R., Arat M., Soydan E., TÖRÜNER M., Soykan I., Akbulut H., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.11, sa.2, ss.141-147, 2004 (SCI-Expanded, Scopus)

2004

106. Psychometric and methodological characteristics of a culturally adjusted gastroesophageal reflux disease questionnaire

Kitapcioglu G., Mandiracioglu A., TÖRÜNER M.

DISEASES OF THE ESOPHAGUS , cilt.17, sa.3, ss.228-234, 2004 (SCI-Expanded, Scopus)

2003

107. Eosinophilic bronchitis as a cause of chronic cough

Ayik S., KAÇMAZ BAŞOĞLU Ö., Erdinc M., TÖRÜNER M., Veral A., Bilgen C.

RESPIRATORY MEDICINE , cilt.97, sa.6, ss.695-701, 2003 (SCI-Expanded, Scopus)

2003

108. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux

Bilgen C., Ogut F., Kesimli-Dinc H., Kirazli T., TÖRÜNER M.

JOURNAL OF LARYNGOLOGY AND OTOLOGY , cilt.117, sa.5, ss.386-390, 2003 (SCI-Expanded, Scopus)

2003

109. Effect of hypo- and hyperthyroidism on gastric myoelectrical activity

Gunsar F., Yilmaz S., TÖRÜNER M., Kumanlioglu K., Cetinkalp S., Kabalak T., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.48, sa.4, ss.706-712, 2003 (SCI-Expanded, Scopus)

2003

110. Reversal of iron deficiency anemia in a patient with gastric antral vascular ectasia treated with cyproheptadine

Soykan I., TÖRÜNER M., Idilman R., Ozden A.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.36, sa.2, ss.183-184, 2003 (SCI-Expanded, Scopus)

2002

111. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance - Potential role of lamivudine

Bozkaya H., Yurdaydin C., TÖRÜNER M., Arat M., Bozdayi A., Erekul S., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.47, sa.8, ss.1782-1785, 2002 (SCI-Expanded, Scopus)

2002

112. Is pain experienced during liver biopsy an important factor?

Soykan I., TÖRÜNER M., Sarioglu M., Idilman R.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.35, sa.1, ss.102-103, 2002 (SCI-Expanded, Scopus)

2002

113. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?

Celik T., Aslan N., Goren Z., GÜRDAL H., Degim T., TÖRÜNER M., et al.

JOURNAL OF HEPATOLOGY , cilt.36, ss.29, 2002 (SCI-Expanded)

2001

114. Repopulation of liver endothelial cells, but not hepatocytes, by allogeneic hematopoietic cell transplants.

Idilman R., Tukun A., Erdem E., Arat M., TÖRÜNER M., Soykan I., et al.

BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded)

2001

115. B-cell lymphoproliferative and plasma cell disorders in individuals with chronic hepatitis C.

Idilman R., Colantoni A., De Maria N., Alkan S., Nand S., Soykan I., et al.

HEPATOLOGY , cilt.34, sa.4, 2001 (SCI-Expanded)

2001

116. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?.

Yurdaydin C., Celik T., Goren Z., GÜRDAL H., Degim T., TÖRÜNER M., et al.

HEPATOLOGY , cilt.34, sa.4, 2001 (SCI-Expanded)

2001

117. Gastroesophageal reflux disease in an urban population in Turkey: A model of a developing nation with high H. pylori prevalence

TÖRÜNER M., Mandiracioglu A., Kitapcioglu G., Caymaz-Bor C., Zeytinoglu H., Gilbert R.

GASTROENTEROLOGY , cilt.120, sa.5, 2001 (SCI-Expanded, Scopus)

1999

118. Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats?

Yuceyar H., Ozutemiz O., Huseyinov A., Saruc M., Alkanat M., TÖRÜNER M., et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , cilt.61, sa.6, ss.339-345, 1999 (SCI-Expanded, Scopus)

1999

119. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat

Shah V., TÖRÜNER M., Haddad F., Cadelina G., Papapetropoulos A., Choo K., et al.

GASTROENTEROLOGY , cilt.117, sa.5, ss.1222-1228, 1999 (SCI-Expanded, Scopus)

1999

120. Bioactivation of nitroglycerin and vasomotor response to nitric oxide is impaired in cirrhotic rat livers.

Dudenhoefer A., TÖRÜNER M., Cadelina G., Groszmann R.

HEPATOLOGY , cilt.30, sa.4, 1999 (SCI-Expanded, Scopus)

1999

121. Mechanisms of basolateral Na+ transport in rabbit esophageal epithelial cells

Abdulnour-Nakhoul S., TÖRÜNER M., Imeryuz N., Orlando R.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , cilt.276, sa.2, 1999 (SCI-Expanded, Scopus)

1999

122. Esophageal exposure to ethanol increases risk of acid damage in rabbit esophagus

TÖRÜNER M., Bor-Caymaz C., Tobey N., Abdulnour-Nakhoul S., Orlando R.

DIGESTIVE DISEASES AND SCIENCES , cilt.44, sa.2, ss.290-300, 1999 (SCI-Expanded, Scopus)

1998

123. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

Gupta T., TÖRÜNER M., Chung M., Groszmann R.

HEPATOLOGY , cilt.28, sa.4, ss.926-931, 1998 (SCI-Expanded, Scopus)

1998

124. Role of nitric oxide

Gupta T., TÖRÜNER M., Groszmann R.

DIGESTION , cilt.59, sa.4, ss.413-415, 1998 (SCI-Expanded, Scopus)

1998

125. Impaired nitric oxide release in cirrhotic rat liver.

Haddad F., TÖRÜNER M., Shah V., Gupta T., Groszmann R.

GASTROENTEROLOGY , cilt.114, sa.4, 1998 (SCI-Expanded)

1996

126. Hemorrhagic cystitis after bone marrow transplantation: The role of electron microscopy in differential diagnosis.

GÜRMAN G., Sencer H., Uysal A., Cinar K., Arslan O., Ozcan M., et al.

BLOOD , cilt.88, sa.10, ss.3747, 1996 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

2024

1. Age matters! Defining the diversity in upper gastrointestinal involvement in infammatory bowel disease

Kahraman H., Berber H., Jevtic J., Bol A., Davaji J., Özdemir S., et al.

36th European Congress of Pathology, Florence, İtalya, 7 Eylül - 11 Ekim 2024, ss.1-546, (Özet Bildiri)

2022

2. Enflamatuvar Barsak Hastalığı Tanılı Hastalarda Sitomegalovirüs Enfeksiyonlarının Değerlendirilmesi

İNAN M., SARICAOĞLU E. M., ÇINAR G., AKDEMİR İ., GÜLTEN E., ENSARİ A., et al.

10. Türkiye EKMUD Bilimsel Kongresi, 25 - 29 Mayıs 2022, (Özet Bildiri)

2022

3. Enflamatuar Barsak Hastalığı Tanılı Hastalarda Sitomegalovirüs Enfeksiyonlarının Değerlendirilmesi

İnan M., Sarıcaoğlu E. M., Çınar G., Akdemir Kalkan İ., Gülten E., Ensari A., et al.

10. Türkiye EKMUD Bilimsel Kongresi, Antalya, Türkiye, 25 - 29 Mayıs 2022, ss.130, (Tam Metin Bildiri)

2020

4. Hermasky-Pudlak Syndrome: A Case Report

TAŞDELEN E., KAPLAN İ., TÖRÜNER M., ILGIN RUHİ H.

1. Bursa Uluslararası Katılımlı Genetik Günleri Dermatogenetik Sempozyumu, Türkiye, 9 - 11 Ocak 2020, (Özet Bildiri)

2019

5. Population Based Assesment of Gastrointestinal Symptoms and Diseases: Cappadocia Cohort, Turkey

SEZGİN O., Akpınar H., ÖZER B., TÖRÜNER M., BAL K., BOR S.

UEGW 2019, Barselona, 19 - 23 Ekim 2019, (Özet Bildiri)

2019

6. Incidence and Indicators of Suboptimal Response to Tumor Necrosis Factor Antagonist Therapy in Inflammatory Bowel Disease in Newly Industrialized Countries: Results From the EXPLORE Study

Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., Shapina M., et al.

Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), San-Antonio, Kuzey Mariana Adaları, 25 - 30 Ekim 2019, cilt.114, (Özet Bildiri)

2019

7. Serum or urinary neopterin which is the best for evaluate disease activity in inflammatory bowel disease?

ÇETİNKAYA H., MELEKOĞLU ELLİK Z., KENARLI K., DUMAN S., EVREN E., KARAHAN Z. C., et al.

Proceedings of the World Congress of Gastroenterology, İstanbul, Türkiye, 21 - 24 Eylül 2019, cilt.30, ss.810, (Özet Bildiri)

2019

8. EVIDENCE BASED RECOMMENDATIONS FOR THE MANAGEMENT OF ENTEROPATHIC ARTHRITIS: A RHEUMATOLOGY, GASTROENTEROLOGY COLLABORATIVE INITIATIVE

HATEMİ G., AKAR S., AKARSU M., ATAGÜNDÜZ M. P., BENGİ G., CAN G., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.881, (Özet Bildiri)

2018

9. Surgical Rates for Crohn’xxs Disease: A monocentric Cross Section Study from Turkey

Bulat B., Köken e., Bilgiç C., AKYOL C., özel m., Kenarlı K., et al.

Falk Syposium No:213, 5 - 06 Ekim 2018, (Özet Bildiri)

2018

10. Managing IBD in Rheumatic Diseases

TÖRÜNER M.

Ninth International Immunology Summit, 8 - 10 Mart 2018

2018

11. Managing IBD in Rheumatic Disease

TÖRÜNER M.

Ninth International Immunology Summit, Çek Cumhuriyeti, 8 - 10 Mart 2018, (Tam Metin Bildiri)

2017

12. İNFLAMATUVAR BARSAK HASTALIĞI’NDASITOMEGALOVIRÜS (CMV) ENFEKSIYONU SIKLIĞIRISK FAKTÖRLERI VE KLINIK SEYIR

MANTI B., TÖRÜNER M., KESKİN O.

34. Ulusal Gastroenteroloji Haftası, Türkiye, 1 - 06 Aralık 2017, (Özet Bildiri)

2017

13. Cytomegalovirus Infection in IBD: Single Center Experience

Manti B., Keskin O., TÖRÜNER M.

82nd Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Florida, Amerika Birleşik Devletleri, 13 - 18 Ekim 2017, cilt.112, (Özet Bildiri)

2017

14. Case Report: Post-Liver Transplant Crohn's Disease Refractory to Anti-tumor Necrosis Factor Agents

Yilmaz Y., Keskin O., TÖRÜNER M.

82nd Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Florida, Amerika Birleşik Devletleri, 13 - 18 Ekim 2017, cilt.112, (Özet Bildiri)

2017

15. Treatment Algorithms in Crohn’xxs disease in daily practice

TÖRÜNER M.

16th International Euroasian Congress of Gastroenterology and Surgery, 27 - 30 Nisan 2017, (Tam Metin Bildiri)

2017

16. P401 Anti-TNF treatments in Crohn s disease and improvement in work productivity and quality of life: an observational study from Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., ŞENTÜRK Ö., AKYÜZ F., ÜNSAL B., et al.

ECCO (EUROPEAN CROHNS AND COLITIS ORGANISATION), Barcelona, İspanya, 15 - 18 Şubat 2017, (Özet Bildiri)

2017

17. Anti-TNF treatments in Crohn’xxs disease and improvement in work productivity and quality of life: an observational study from Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., ŞENTÜRK Ö., AKYÜZ F., ÜNSAL B., et al.

JOURNAL OF CROHNS COLITIS, 01 Şubat 2017, cilt.11, ss.281, (Özet Bildiri)

2016

18. Inflammatory Bowel Diseases

TÖRÜNER M.

FLORIDA INT UNIVERSITY, DEPT. SURGERY - GRAND ROUNDS, 18 Kasım 2016, (Tam Metin Bildiri)

2016

19. Crohn hastalığına bağlı enteroenetrik fistüller MR enterografi kl n k laboratuar ve endoskopi bulgularının değerlendirilmesi

ünal s., AKKAYA H. E., onay m., ÇALIŞKAN KARTAL A., bıyıklı gençtürk z., TÖRÜNER M., et al.

37. Ulusal Radyoloji Kongresi, Türkiye, 1 - 05 Kasım 2016, (Tam Metin Bildiri)

2016

20. MR enterografi, klinik, laboratuvar ve endoskopik bulguların değerlendirilmesi

ÜNAL S., AKKAYA H. E., ONAY M., ÇALIŞKAN KARTAL A., BIYIKLI GENÇTÜRK Z., TÖRÜNER M., et al.

37. Ulusal Radyoloji Kongresi, Türkiye, 1 - 05 Kasım 2016, (Tam Metin Bildiri)

2016

21. Serum Vitamin D levels have some effects on Sexual dysfunction and health quality in Turkish IBD patients

TÖRÜNER M., Ateş E., ÇALIŞKAN KARTAL A., ÇETİNKAYA H., SOYKAN A. İ.

IMKASID 2016, 15 - 16 Nisan 2016, (Tam Metin Bildiri)

2015

22. ERAP1 Gene polymorphisms in Turkish Patients with inflammatory bowel disease and ankylosing spondylitis

ÇETİNKAYA H., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KÜÇÜKŞAHİN O., BEKTAŞ M., et al.

Falk Symposium No: 200, 16 - 17 Ekim 2015

2015

23. IBD and Behçet s disease

TÖRÜNER M.

PanHellenic IBD Symposium, 5 - 06 Haziran 2015

2015

24. Health Quality and Sexual Dysfunction in Turkish IBD Patients

TÖRÜNER M., Ateş E., KALKAN Ç., KARAKAYA M. F., ÇETİNKAYA H., SOYKAN A. İ.

ECCO, 1 - 05 Şubat 2015

2014

25. ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) IN PROSPECTIVE GENES AND SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS, INFLAMMATORY BOWEL DISEASE IN A TURKISH POPULATION

KÜÇÜKŞAHİN O., Ates A., Turkcapar N., TÖRÜNER M., Duman T., Sahin A., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.807, (Özet Bildiri)

2014

26. THE FREQUENCY OF SPONDYLOARTHROPATHY IN INFLAMMATORY BOWEL DISEASES

KÜÇÜKŞAHİN O., Ates A., TÖRÜNER M., Turkcapar N., Sahin A., Turgay M., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.1040, (Özet Bildiri)

2014

27. ERAP 1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and ankylosing spondylitis

KÜÇÜKŞAHİN O., TÜRKÇAPAR N., TÖRÜNER M., DUMAN T., ÇETİNKAYA H., TURGAY T. M., et al.

ECCO 2014, 20 - 22 Şubat 2014, cilt.32, ss.631, (Özet Bildiri)

2013

28. Tumor necrosis factor inhibitors and acute leukemia in two cases.

Ozen M., Keskin O., KÜÇÜKŞAHİN O., Ilgen U., Topcuoglu P., Turgay M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

2012

29. Interleukin 23 Receptor, and ATG16L1 Gene Polymorphisms in Inflammatory Bowel Diseases, and the Association With the Clinical Course

Kabacam G., Karatayli S. C., Keskin O., Bektas M., Cetinkaya H., Palabiyikoglu M., et al.

Digestive Disease Week (DDW), California, Amerika Birleşik Devletleri, 19 - 22 Mayıs 2012, cilt.142, (Özet Bildiri)

2010

30. Cost Analysis in Ankara University School of Medicine Hospitals

ESATOĞLU A. E., AĞIRBAŞ İ., DOĞANAY PAYZİNER P., GÖKTAŞ B., AKBULUT Y., özatkan y., et al.

ISPOR 13th Annual European Congress, 6 - 09 Kasım 2010

2009

31. Clinical and Laboratory Features of Patients with Significantly Elevated Serum Gastrin Level

Kabacam G., Bektas M., Ustun Y., Yakut M., TÖRÜNER M., Cetinkaya H., et al.

Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 04 Haziran 2009, cilt.136, (Özet Bildiri)

2008

32. DRUG INDUCED LIVER INJURY: A SINGLE CENTER EXPERIENCE OVER A 7-YEAR PERIOD

Bektas M., Idilmon R., Cerit T., ÇINAR K., TÖRÜNER M., Soykan I., et al.

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48, (Özet Bildiri)

2007

33. Bacterial and viral infections mimicking inflammatory bowel diseases

TÖRÜNER M.

Falk Symposium 159 on IBD 2007 - Achievements in Research and Clinical Practice, İstanbul, Türkiye, 4 - 05 Mayıs 2007, cilt.159, ss.54-59, (Tam Metin Bildiri)

2007

34. Comparison of chromoscopic magnifying colonoscopy and convetional colonoscopy for colorectal cancer screening: Preliminary results

Cetinkaya H., Bektas M., Kahramanoglu E., Tuzun A., Savas B., TÖRÜNER M., et al.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri)

2007

35. Role of magnifying chromoendoscopy in differentiating adenomatous and non-adenomatous colonic lesions

TÖRÜNER M., Cetinkaya H., Tuzun A. E., Bektas M., Kahramanoglu E., Savas B., et al.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri)

2006

36. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases

Colombel J., TÖRÜNER M.

Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases, Berlin, Almanya, 6 - 07 Mayıs 2006, cilt.153, ss.85-98, (Tam Metin Bildiri)

2006

37. Risk factors for opportunistic infections in inflammatory bowel diseases: A case-control study

TÖRÜNER M., Loftus E. V., Colombel J. F., Orenstein R., Harmsen W. S., Zinsmeister A. R., et al.

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Şili, 19 - 24 Mayıs 2006, cilt.130, (Özet Bildiri)

2006

38. Chromoscopic magnifying colonoscopy for colorectal cancer screening: Is it a better tool?

Cetinkaya H., Tuzun A., Bektas M., TÖRÜNER M., ENSARİ A., Soykan I., et al.

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Şili, 19 - 24 Mayıs 2006, cilt.130, (Özet Bildiri)

2006

39. The effect of Helicobacter pylori eradication on gastroesophageal reflux, gastrointestinal symptoms and quality of life in patients with functional dyspepsia

Soykan I., Bektas M., TÖRÜNER M., Cetinkaya H., Ozden A.

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Şili, 19 - 24 Mayıs 2006, cilt.130, (Özet Bildiri)

2005

40. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Turkcapar N., TÖRÜNER M., Soykan I., Aydintug O., Cetinkaya H., Duzgun N., et al.

69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 12 - 17 Kasım 2005, cilt.52, (Özet Bildiri)

2005

41. Loss of extracellular attachment triggers an NF-kappa B-mediated survival cascade in intestinal epithelial cells

TÖRÜNER M., Fernandez-Zapico M., Myhre G., Urrutia R., Egan L.

Digestive Disease Week Meeting/106th Annual Meeting of the American-Gastroenterological-Association, Illinois, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128, (Özet Bildiri)

2005

42. Does heartburn in pregnancy increase the risk of gastroesophageal reflux disease?

Dettmar P., Kitapcioglu G., TÖRÜNER M.

Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128, (Özet Bildiri)

2005

43. C-Jun N-terminal inhibits intestinal epithelial cell anoikis downstream of survival factor nk-kappa B

TÖRÜNER M., Egan L.

Digestive Disease Week Meeting/106th Annual Meeting of the American-Gastroenterological-Association, Illinois, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128, (Özet Bildiri)

2004

44. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

TÖRÜNER M., Harewood G., Loftus E., Sandborn W., Tremaine W., Faubion W., et al.

69th Annual Scientific Meeting of the American-College-of-Gastroentrology, Florida, Amerika Birleşik Devletleri, 29 Ekim - 03 Kasım 2004, cilt.99, (Özet Bildiri)

2004

45. Comparison of liver functional parameters with serum fibrosis markers as predictors of severe necro-inflammation in patients with chronic hepatitis B and D

Yurdaydin C., TÖRÜNER M., Bozkaya H., Okcu-Heper A., Voelker M., Erden E., et al.

39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Almanya, 14 - 18 Nisan 2004, cilt.40, ss.133, (Özet Bildiri)

2004

46. Effect of interferon alpha in dextran sulfate sodium induced colitis in mice

Soykan I., TÖRÜNER M., ENSARİ A., Gecim E., Coban S., Cetinkaya H., et al.

Digestive Disease Week/105th Annual Meeting of the American-Gastroenterological-Association, Louisiana, Amerika Birleşik Devletleri, 16 - 19 Mayıs 2004, cilt.126, (Özet Bildiri)

2003

47. In Sjogren's syndrome gastroesophageal reflux disease is not related with disturbances on gastric myoelectrical activity

Turk T., Celebi A., TÖRÜNER M., Keser G., Kabasakal Y., Doganavsargil E.

Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.463, (Özet Bildiri)

2003

48. The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation

Idilman R., Soydan E., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146, (Özet Bildiri)

2003

49. Two year interferon treatment of chronic delta hepatitis

Yurdaydin C., Bozkaya H., Erkan O., Karaarslan H., TÖRÜNER M., Cinar K., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.183-184, (Özet Bildiri)

2003

50. Lamivudine prophylaxis for prevention of chemotherapy induced hepatitis B virus reactivation in hepatitis B virus carriers with hematological malignancies

Idilman R., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., Soydan E., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146-147, (Özet Bildiri)

2003

51. The effect of Saccharomyces boulardii on gastrointestinal symptoms and Helicobacter pylori eradication in patients with functional dyspepsia

Soykan I., TÖRÜNER M., Temizkan A., Ozden A.

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124, (Özet Bildiri)

2002

52. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?

Celik T., Goren M., Gurdal H., Cinar K., TÖRÜNER M., Degim T., et al.

11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism, Amsterdam, Hollanda, 30 Mayıs - 01 Haziran 2002, ss.165-171, (Tam Metin Bildiri)

2002

53. The efficciency of ursodeoxycholic acid in treatment of limited chronic graft versus host disease of the liver.

Arat M., Idilman R., Soydan E., TÖRÜNER M., Akan H.

44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 Aralık 2002, cilt.100, (Özet Bildiri)

2002

54. The long-term ursodeoxycholic acid treatment of chronic graft-versus-host disease of the liver.

Idilman R., Arat M., TÖRÜNER M., Soydan E., Soykan I., Erden E., et al.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 Kasım 2002, cilt.36, (Özet Bildiri)

Kitaplar

2024

1. İBH'de Ekstraintestinal Bulguların Tedaviye Etkisi

Telli P., Törüner M.

İnflamatuvar Bağırsak Hastalığı Uzman Görüş Raporu, AKPINAR HALE,AKYÜZ FİLİZ,ARHAN MEHMET,ÇELİK AYKUT FERHAT,HATEMİ ALİ İBRAHİM,KALKAN İSMAİL HAKKI,KAV TAYLAN,TEZEL HÜSEYİN AHMET,TÖRÜNER MURAT, Editör, İnflamatuvar Barsak Hastalıkları Derneği, İstanbul, ss.138-139, 2024

2024

2. Crohn Hastalığında Tedavi

TELLİ P., TÖRÜNER M.

İnflamatuar Bağırsak Hastalıkları Uzman Görüş Raporu, AKPINAR HALE, AKYÜZ FİLİZ, ARHAN MEHMET, ÇELİK AYKUT FERHAT, HATEMİ ALİ İBRAHİM, KALKAN İSMAİL HAKKI, KAV TAYLAN, TEZEL HÜSEYİN AHMET, TÖRÜNER MURAT, Editör, İnflamatuvar Barsak Hastalıkları Derneği, ss.102-111, 2024

2022

3. Inflammatory Bowel Disease

Törüner M.

Rare Causes of Stroke, Derya Uluduz,Anita Arsovska, Editör, Cambridge University Press, Cambridge (MA), USA , Cambridge, ss.92-98, 2022

Bilimsel Dergilerdeki Faaliyetler

2018 - Devam Ediyor

FRONTIERS IN MEDICINE

Yardımcı Editör/Bölüm Editörü

2019 - 2023

TURKISH JOURNAL OF GASTROENTEROLOGY

Editör

Bilimsel Kuruluşlardaki Üyelikler / Görevler

2023 - Devam Ediyor

ECCO Clinical Research Committee

Bilim Kurulu Üyesi

2021 - Devam Ediyor

İnflamatuvar Barsak Hastalıkları Derneği

Başkan Yardımcısı

2017 - Devam Ediyor

European Crohn's and Colitis Asscoiation

Üye

2017 - 2019

Türk Gastroenteroloji Derneği

Genel Sekreter

2013 - 2017

ECCO

Ülke Temsilcisi

Bilimsel Yayınlarda Hakemlikler

Ocak 2023

FRONTIERS IN MEDICINE

SSCI Kapsamındaki Dergi

Aralık 2022

FRONTIERS OF MEDICINE

SSCI Kapsamındaki Dergi

Kongre ve Sempozyum Katılımı Faaliyetleri

26 Kasım 2024 - 01 Aralık 2024

41. Ulusal Gastroenteroloji Haftası

Oturum Başkanı

Antalya-Türkiye

26 Kasım 2024 - 01 Aralık 2024

41. Ulusal Gastroenteroloji Haftası

Davetli Konuşmacı

Antalya-Türkiye

26 Kasım 2024 - 01 Aralık 2024

41. Ulusal Gastroenteroloji Haftası

Moderatör

Antalya-Türkiye

30 Mayıs 2024 - 02 Haziran 2024

İnflamatuvar Barsak HAstalıkları Günleri

Davetli Konuşmacı

İstanbul-Türkiye

30 Mayıs 2024 - 02 Haziran 2024

İnflamatuvar Barsak Hastalıkları Günleri

Oturum Başkanı

İstanbul-Türkiye

08 Aralık 2023 - 09 Aralık 2023

Pediatrik - Yetişkin İBH Buluşması

Davetli Konuşmacı

Ankara-Türkiye

31 Mayıs 2023 - 03 Haziran 2023

12. Ulusal İBH Günleri

Oturum Başkanı

İstanbul-Türkiye

31 Mayıs 2023 - 03 Haziran 2023

12. Ulusal İBH Günleri

Davetli Konuşmacı

İstanbul-Türkiye

23 Kasım 2022 - 27 Kasım 2022

Ulusal Gastroenteroloji Haftası

Oturum Başkanı

Antalya-Türkiye

01 Haziran 2021 - 03 Haziran 2021

İnflamatuvar Barsak Hastalıkları Okulu

Davetli Konuşmacı

İstanbul-Türkiye

05 Haziran 2015 - 07 Haziran 2015

14. Panhellenic Congress on IBD

Davetli Konuşmacı

Athens-Yunanistan

Atıflar

Toplam Atıf Sayısı (SCOPUS): 4203

h-indeksi (SCOPUS): 29

Jüri Üyelikleri

Mayıs-2023

Mayıs 2023

Doçentlik Sınavı

Mustafa Zanyar Akkuzu Eser innceleme - Ankara University

Aralık-2022

Aralık 2022

Akademik Kadroya Atama-Yardımcı Doçentlik

Dr. Muhammet Fatih Karakaya, Doktor Öğretim Üyeliği Atama - Ankara Üniversitesi

Ekim-2022

Ekim 2022